Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 5.81% is 91% above its 5-year average of 3.04%, near the high end of its 5-year range (-0.72%–8.14%).
26.17% above its 12-month average of 4.61%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 2.42%.
RETURN ON ASSETS (ROA)
5.81%
RETURN ON ASSETS (ROA) AVG TTM
4.61%
RETURN ON ASSETS (ROA) AVG 3Y
2.71%
RETURN ON ASSETS (ROA) AVG 5Y
3.04%
RETURN ON ASSETS (ROA) AVG 10Y
3.19%
RETURN ON ASSETS (ROA) AVG 15Y
0.28%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+26.17%
CURRENT VS 3Y AVG
+114.79%
CURRENT VS 5Y AVG
+90.91%
CURRENT VS 10Y AVG
+82.34%
CURRENT VS 15Y AVG
+1998.42%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.75%
median of 719 covered companies
CURRENT VS SECTOR MEDIAN
+118.89%
vs the sector median at left
Kamada Ltd.
Market Cap
$472.48M
Return on Assets (ROA)
5.81%
TTM Avg
4.61%
3Y Avg
2.71%
5Y Avg
3.04%
Market Cap
$474.22M
Return on Assets (ROA)
-22.99%
TTM Avg
-20.77%
3Y Avg
-18.00%
5Y Avg
-22.63%
Market Cap
$475.46M
Return on Assets (ROA)
-3.31%
TTM Avg
-8.72%
3Y Avg
-14.01%
5Y Avg
-17.66%
Market Cap
$477.27M
Return on Assets (ROA)
-8.14%
TTM Avg
-30.20%
3Y Avg
-72.84%
5Y Avg
-64.85%
Market Cap
$478.75M
Return on Assets (ROA)
1.38%
TTM Avg
-14.74%
3Y Avg
-19.98%
5Y Avg
-18.10%
Market Cap
$462.12M
Return on Assets (ROA)
4.30%
TTM Avg
13.65%
3Y Avg
19.24%
5Y Avg
21.45%
Market Cap
$486.85M
Return on Assets (ROA)
13.86%
TTM Avg
14.29%
3Y Avg
9.48%
5Y Avg
0.09%
Market Cap
$491.28M
Return on Assets (ROA)
-13.84%
TTM Avg
-22.27%
3Y Avg
-29.75%
5Y Avg
-35.86%
Market Cap
$451.59M
Return on Assets (ROA)
-83.42%
TTM Avg
-53.06%
3Y Avg
-45.42%
5Y Avg
-42.54%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kamada Ltd. (KMDA) | $472.48M | 5.81% | 4.61% | 2.71% | 3.04% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $474.22M | -22.99% | -20.77% | -18.00% | -22.63% |
| Cerus Corporation (CERS)vs › | $475.46M | -3.31% | -8.72% | -14.01% | -17.66% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $477.27M | -8.14% | -30.20% | -72.84% | -64.85% |
| Arvinas, Inc. (ARVN)vs › | $478.75M | 1.38% | -14.74% | -19.98% | -18.10% |
| NRC Health (NRC)vs › | $462.12M | 4.30% | 13.65% | 19.24% | 21.45% |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.85M | 13.86% | 14.29% | 9.48% | 0.09% |
| Evolus, Inc. (EOLS)vs › | $491.28M | -13.84% | -22.27% | -29.75% | -35.86% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $451.59M | -83.42% | -53.06% | -45.42% | -42.54% |
| Ovid Therapeutics Inc. (OVID)vs › | $449.80M | -14.87% | -20.11% | -27.86% | -25.84% |
ROA
5.8%
ROE
8.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 5.33% |
| 2024-12-31 | 3.88% |
| 2023-12-31 | 2.33% |
| 2022-12-31 | -0.72% |
| 2021-12-31 | -0.70% |
| 2020-12-31 | 8.14% |
| 2019-12-31 | 12.80% |
| 2018-12-31 | 16.14% |
| 2017-12-31 | 5.65% |
| 2016-12-31 | -6.75% |
| 2015-12-31 | -11.05% |
| 2014-12-31 | -10.56% |
| 2013-12-31 | 0.32% |
| 2012-12-31 | 0.29% |
| 2011-12-31 | -4.09% |
| 2010-12-31 | -16.58% |
| 2009-12-31 | -35.02% |
| 2008-12-31 | -29.59% |
| 2007-12-31 | 0.00% |
